NO148745C - Analogifremgangsmaate for fremstilling av farmakologisk aktive dibenzo(b,d)pyranderivater - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive dibenzo(b,d)pyranderivater

Info

Publication number
NO148745C
NO148745C NO763725A NO763725A NO148745C NO 148745 C NO148745 C NO 148745C NO 763725 A NO763725 A NO 763725A NO 763725 A NO763725 A NO 763725A NO 148745 C NO148745 C NO 148745C
Authority
NO
Norway
Prior art keywords
pyrander
derivatives
preparation
pharmacologically active
analogy procedure
Prior art date
Application number
NO763725A
Other languages
English (en)
Norwegian (no)
Other versions
NO148745B (no
NO763725L (da
Inventor
Jasjit Singh Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO763725L publication Critical patent/NO763725L/no
Priority to NO771816A priority Critical patent/NO148746C/no
Publication of NO148745B publication Critical patent/NO148745B/no
Publication of NO148745C publication Critical patent/NO148745C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO763725A 1975-11-03 1976-11-02 Analogifremgangsmaate for fremstilling av farmakologisk aktive dibenzo(b,d)pyranderivater NO148745C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO771816A NO148746C (no) 1975-11-03 1977-05-24 Mellomprodukter for anvendelse ved fremstilling av farmakologisk aktive dibenzo(b,d)pyranderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62821075A 1975-11-03 1975-11-03

Publications (3)

Publication Number Publication Date
NO763725L NO763725L (da) 1977-05-04
NO148745B NO148745B (no) 1983-08-29
NO148745C true NO148745C (no) 1983-12-07

Family

ID=24517939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763725A NO148745C (no) 1975-11-03 1976-11-02 Analogifremgangsmaate for fremstilling av farmakologisk aktive dibenzo(b,d)pyranderivater

Country Status (25)

Country Link
JP (3) JPS5277065A (da)
AR (1) AR220521A1 (da)
BG (3) BG27552A3 (da)
CA (1) CA1099269A (da)
CH (1) CH622790A5 (da)
CS (1) CS207571B2 (da)
DD (3) DD129214A5 (da)
DK (1) DK495876A (da)
EG (1) EG12648A (da)
ES (3) ES452772A1 (da)
FI (1) FI763131A7 (da)
GR (1) GR65202B (da)
HU (1) HU178321B (da)
IE (1) IE43700B1 (da)
IL (1) IL50717A (da)
NO (1) NO148745C (da)
NZ (1) NZ182368A (da)
PH (3) PH14811A (da)
PL (1) PL125297B1 (da)
PT (1) PT65781B (da)
RO (4) RO76124A (da)
SE (1) SE432251B (da)
SU (4) SU843748A3 (da)
YU (1) YU268176A (da)
ZA (1) ZA766281B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0765890A (ja) * 1993-08-26 1995-03-10 Sumitomo Wiring Syst Ltd コネクタ
JP2988237B2 (ja) * 1994-01-31 1999-12-13 住友電装株式会社 簡易防水コネクタ
JP5037799B2 (ja) * 2005-06-30 2012-10-03 パナソニック株式会社 テレビコンセント
JP7516898B2 (ja) 2020-06-16 2024-07-17 株式会社アイシン シフト装置

Also Published As

Publication number Publication date
PH14383A (en) 1981-06-24
CS207571B2 (en) 1981-08-31
FI763131A7 (da) 1977-05-04
SE7611275L (sv) 1977-06-27
ES462784A1 (es) 1978-06-01
DD129214A5 (de) 1978-01-04
AR220521A1 (es) 1980-11-14
RO75876A (ro) 1981-05-30
CA1099269A (en) 1981-04-14
JPS56103173A (en) 1981-08-18
PL125297B1 (en) 1983-04-30
DK495876A (da) 1977-05-04
IL50717A0 (en) 1976-12-31
DD137837A5 (de) 1979-09-26
BG27552A3 (bg) 1979-11-12
NO148745B (no) 1983-08-29
ES452772A1 (es) 1978-02-16
PT65781A (en) 1976-12-01
RO76124A (ro) 1981-04-30
DD143774A5 (de) 1980-09-10
SU677660A3 (ru) 1979-07-30
SU843748A3 (ru) 1981-06-30
IE43700L (en) 1977-05-03
NZ182368A (en) 1978-04-03
SU677661A3 (ru) 1979-07-30
IL50717A (en) 1981-09-13
IE43700B1 (en) 1981-05-06
JPS564555B2 (da) 1981-01-30
JPS5943958B2 (ja) 1984-10-25
PT65781B (en) 1978-05-10
RO71411A (ro) 1982-12-06
GR65202B (en) 1980-07-29
BG28057A4 (bg) 1980-02-25
PH14811A (en) 1981-12-14
BG28058A4 (bg) 1980-02-25
YU268176A (en) 1983-10-31
HU178321B (en) 1982-04-28
JPS5589280A (en) 1980-07-05
EG12648A (en) 1979-06-30
JPS5277065A (en) 1977-06-29
CH622790A5 (en) 1981-04-30
RO76006A (ro) 1981-03-30
SE432251B (sv) 1984-03-26
ES462783A1 (es) 1978-06-01
SU784772A4 (ru) 1980-11-30
ZA766281B (en) 1977-09-28
JPS5943955B2 (ja) 1984-10-25
PH16788A (en) 1984-02-28
PL193435A1 (da) 1980-01-28
NO763725L (da) 1977-05-04

Similar Documents

Publication Publication Date Title
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO142172C (no) Analogifremgangsmaate for fremstilling av som antikonvulsiva virksomme alfa-fenyl-benzyliden-aminosyrederivater
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO149388C (no) Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
NO143744C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benz(de)isokinolin-derivater
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
NO142403C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
SE428688B (sv) Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
NO147306C (no) Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE417091B (sv) Forfarande att framstella farmakologiskt aktiva derivat av 2-karboxialkyl-4,4dimetyl-pyrrolidin-5-on
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner